We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEN.B icon
1376
Lennar Class B
LEN.B
$20.7B
$4.84K ﹤0.01%
29
– –
MJ icon
1377
Amplify Alternative Harvest ETF
MJ
$98.2M
$4K ﹤0.01%
101
– –
IUSV icon
1378
iShares Core S&P US Value ETF
IUSV
$27.5B
$3.82K ﹤0.01%
40
– –
EWY icon
1379
iShares MSCI South Korea ETF
EWY
$21.1B
$3.71K ﹤0.01%
+58
New +$3.76K
QEFA icon
1380
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.05B
$3.62K ﹤0.01%
45
– –
TRTX
1381
TPG RE Finance Trust
TRTX
$660M
$3.05K ﹤0.01%
358
– –
VOOV icon
1382
Vanguard S&P 500 Value ETF
VOOV
$6.67B
$2.1K ﹤0.01%
11
– –
GREK
1383
Global X MSCI Greece ETF
GREK
$291M
$2.07K ﹤0.01%
48
– –
PARAA
1384
DELISTED
Paramount Global Class A
PARAA
$1.57K ﹤0.01%
+72
New +$1.59K
PEJ icon
1385
Invesco Leisure and Entertainment ETF
PEJ
$263M
$858 ﹤0.01%
18
– –
ALE
1386
DELISTED
Allete
ALE
– –
-4,587
Closed -$286K
APPF icon
1387
AppFolio
APPF
$6.31B
– –
-2,235
Closed -$547K
ARCC icon
1388
Ares Capital
ARCC
$13.7B
– –
-11,168
Closed -$233K
ASO icon
1389
Academy Sports + Outdoors
ASO
$3.13B
– –
-9,233
Closed -$492K
AZEK
1390
DELISTED
The AZEK Co
AZEK
– –
-11,566
Closed -$487K
BRBR icon
1391
BellRing Brands
BRBR
$1.59B
– –
-8,509
Closed -$486K
CHRD icon
1392
Chord Energy
CHRD
$7.25B
– –
-3,592
Closed -$602K
CLF icon
1393
Cleveland-Cliffs
CLF
$6.84B
– –
-10,470
Closed -$161K
CLOU icon
1394
Global X Cloud Computing ETF
CLOU
$231M
– –
-1,614
Closed -$31.7K
CNA icon
1395
CNA Financial
CNA
$15B
– –
-5,702
Closed -$263K
DPZ icon
1396
Domino's
DPZ
$11.6B
– –
-473
Closed -$244K
DXCM icon
1397
DexCom
DXCM
$28.9B
– –
-5,056
Closed -$573K
ENPH icon
1398
Enphase Energy
ENPH
$4.79B
– –
-2,288
Closed -$228K
FBIN icon
1399
Fortune Brands Innovations
FBIN
$6.09B
– –
-4,048
Closed -$263K
FHI icon
1400
Federated Hermes
FHI
$4.59B
– –
-7,500
Closed -$247K
54 55
56
57 58

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.